Screener
NewAmsterdam Pharma Company NAMS Goodwill and intangible assets, net
Goodwill and intangible assets, net at other companies
Other financials
Where this comes from
Reported directly by NewAmsterdam Pharma Company in its filing.
Tagged under the XBRL concept us-gaap:IntangibleAssetsNetIncludingGoodwill.
The source filing: NewAmsterdam Pharma Company’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 7:06 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-333824
| Line item | June 30,2026 | December 31,2025 |
|---|---|---|
| Marketable securities, net of current portion | 44,409 | 92,609 |
| Property, plant and equipment, net | 411 | 383 |
| Operating right of use asset | 82 | 185 |
| Intangible assets | 343 | 407 |
| Total assets | 704,452 | 769,284 |
| Liabilities and Shareholders' Equity | ||
| Current liabilities: | ||
| Accounts payable | 5,422 | 8,970 |
Item 1. Financial Statements.
FAQ
- What is NewAmsterdam Pharma Company's goodwill and intangible assets, net?
- NewAmsterdam Pharma Company (NAMS) reported goodwill and intangible assets, net of $343K in Q2 2026.
- How has NewAmsterdam Pharma Company's goodwill and intangible assets, net changed year-over-year?
- NewAmsterdam Pharma Company's goodwill and intangible assets, net decreased by 27.0% year-over-year, from $470K to $343K.
- What is the long-term trend for NewAmsterdam Pharma Company's goodwill and intangible assets, net?
- Over 3 years (2022 to 2025), NewAmsterdam Pharma Company's goodwill and intangible assets, net has grown at a 25.1% compound annual growth rate (CAGR), from $208K to $407K.
- What does goodwill and intangible assets, net mean?
- Goodwill and intangible assets, net
Ask your AI about NewAmsterdam Pharma Company's goodwill and intangible assets, net.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude